Pharma BD Deal Intelligence
CEO Dave Holveck called the deal transformative — elevating Endo from pharmaceutical company to diversified urology partner with lithotripsy, BPH, prostate…
Transaction rationale slides: 'Enhanced Revenue Growth Through Diversification... Accretive to adjusted earnings in 2010... Elevates Endo's leadership in…
Endo divested HealthTronics for up to $130M — a substantial write-down from the 2010 $223M purchase price, retrospectively framing the original deal as a…
Source summaries from our enrichment pipeline; follow links for originals.
All 7 sources with sentiment breakdown →
Endo acquired HealthTronics for ~$223M, adding urology medical devices and services to specialty pharma platform.
Assessment window: 5yr post-close.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Endo Pharmaceuticals Inc. / HealthTronics, Inc. (this deal) | 2010 | $223M | 17 |
| Endo Pharmaceuticals Inc. / Algos Pharmaceutical Corporation | 2000 | $250M | 34 |
| Endo Pharmaceuticals Inc. / Indevus Pharmaceuticals, Inc. | 2009 | $370M | 33 |
| Endo Pharmaceuticals Inc. / SkyePharma plc | 2003 | $120M | 17 |
| Endo Pharmaceuticals Inc. / Qualitest Pharmaceuticals | 2010 | $1.2B | 17 |
| Endo Pharmaceuticals Inc. / American Medical Systems Holdings, Inc. | 2011 | $2.9B | 13 |
| Endo Pharmaceuticals Inc. / Penwest Pharmaceuticals Co. | 2010 | $144M | 13 |
← Browse all deals · How we score deals
More: 2010 deals · Endo Pharmaceuticals Inc. deals · Nephrology deals